Clinical characteristics and outcomes of COVID-19 in patients with autoimmune hepatitis: A population-based matched cohort study

BACKGROUND: Patients with autoimmune hepatitis (AIH) require life-long immunosuppressive agents that may increase the risk of poor coronavirus disease 2019 (COVID-19) outcomes. There is a paucity of large data at the population level to assess whether patients with AIH have an increased risk of seve...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnan, Arunkumar, Patel, Ruhee A, Hadi, Yousaf Bashir, Mukherjee, Diptasree, Shabih, Sarah, Thakkar, Shyam, Singh, Shailendra, Woreta, Tinsay A, Alqahtani, Saleh A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896506/
https://www.ncbi.nlm.nih.gov/pubmed/36744163
http://dx.doi.org/10.4254/wjh.v15.i1.68

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896506/
https://www.ncbi.nlm.nih.gov/pubmed/36744163
http://dx.doi.org/10.4254/wjh.v15.i1.68

Ejemplares similares